Lostes-Bardaji, M. J., García-Illescas, D., Valverde, C., & Serrano, C. (2021). Ripretinib in gastrointestinal stromal tumor: The long-awaited step forward. Ther Adv Med Oncol.
Chicago Style citaatLostes-Bardaji, M. Julia, David García-Illescas, Claudia Valverde, en César Serrano. "Ripretinib in Gastrointestinal Stromal Tumor: The Long-awaited Step Forward." Ther Adv Med Oncol 2021.
MLA citatieLostes-Bardaji, M. Julia, David García-Illescas, Claudia Valverde, en César Serrano. "Ripretinib in Gastrointestinal Stromal Tumor: The Long-awaited Step Forward." Ther Adv Med Oncol 2021.
Let op: Deze citaties zijn niet altijd 100% accuraat.